Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 76 citing articles:

Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Audrey Deprince, Joel T. Haas, Bart Staels
Molecular Metabolism (2020) Vol. 42, pp. 101092-101092
Open Access | Times Cited: 361
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations
Calvin Ke, K.M. Venkat Narayan, Juliana C.N. Chan, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 7, pp. 413-432
Open Access | Times Cited: 144
Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury
Maija Dambrova, Coert J. Zuurbier, Vilmantė Borutaitė, et al.
Free Radical Biology and Medicine (2021) Vol. 165, pp. 24-37
Open Access | Times Cited: 118
Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update
Lorraine L. Lipscombe, Sonia Butalia, Kaberi Dasgupta, et al.
Canadian Journal of Diabetes (2020) Vol. 44, Iss. 7, pp. 575-591
Closed Access | Times Cited: 125
Insulin Resistance and Cancer: In Search for a Causal Link
Eusebio Chiefari, Maria Mirabelli, Sandro La Vignera, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11137-11137
Open Access | Times Cited: 84
Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study
Meera M. Dhodapkar, Xiaoting Shi, Reshma Ramachandran, et al.
BMJ (2022), pp. e071752-e071752
Open Access | Times Cited: 40
Mitochondrial Dysfunction and Heart Disease: Critical Appraisal of an Overlooked Association
Giandomenico Bisaccia, Fabrizio Ricci, Sabina Gallina, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 614-614
Open Access | Times Cited: 51
Antidiabetic Drugs in Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review
Mario Muñoz-Jiménez, Alí Zaarkti, Juan Antonio García-Arnés, et al.
Dementia and Geriatric Cognitive Disorders (2020) Vol. 49, Iss. 5, pp. 423-434
Closed Access | Times Cited: 50
Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Maria Assunta Potenza, Luca Sgarra, Vanessa Desantis, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1257-1257
Open Access | Times Cited: 44
The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism
Nicole K.H. Yiew, Brian N. Finck
AJP Endocrinology and Metabolism (2022) Vol. 323, Iss. 1, pp. E33-E52
Open Access | Times Cited: 36
Extracellular Vesicles in Adipose Tissue Communication with the Healthy and Pathological Heart
Lauriane Y. M. Michel
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7745-7745
Open Access | Times Cited: 20
Current and experimental drug therapy for the treatment of polycystic ovarian syndrome
Luigi Della Corte, Virginia Foreste, Fabio Barra, et al.
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 8, pp. 819-830
Closed Access | Times Cited: 47
Nuclear receptors in podocyte biology and glomerular disease
Shipra Agrawal, John Cijiang He, Pierre‐Louis Tharaux
Nature Reviews Nephrology (2020) Vol. 17, Iss. 3, pp. 185-204
Closed Access | Times Cited: 44
Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer’s disease
Mingcui Zheng, Pengwen Wang
3 Biotech (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 39
Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD
João Pedro Ferreira, Francisco Vasques‐Nóvoa, Diana Ferrão, et al.
Diabetes Care (2022) Vol. 45, Iss. 7, pp. 1584-1591
Open Access | Times Cited: 22
The General Principle of the Warburg Effect as a Possible Approach for Cancer Immunotherapy: The Regulatory Effect of Plant Extracts Could Change the Game
Donika Ivanova, Severina Semkova, Boncho Grigorov, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 393-393
Open Access
Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease
Michele Malaguarnera, Omar Cauli, Andrea Cabrera‐Pastor
Biomolecules (2025) Vol. 15, Iss. 2, pp. 231-231
Open Access
The impact of chemical engineering and technological advances on managing diabetes: present and future concepts
Sabine Szunerits, Sorin Melinte, Alexandre Barras, et al.
Chemical Society Reviews (2020) Vol. 50, Iss. 3, pp. 2102-2146
Closed Access | Times Cited: 37
The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use Sodium Glucose Cotransporter 2 inhibitors is now
Michael E. Johansen, Christos Argyropoulos
Clinical Cardiology (2020) Vol. 43, Iss. 12, pp. 1376-1387
Open Access | Times Cited: 34
Sulfur-containing therapeutics in the treatment of Alzheimer’s disease
Haizhou Zhu, Venkateshwara Dronamraju, Wei Xie, et al.
Medicinal Chemistry Research (2021) Vol. 30, Iss. 2, pp. 305-352
Open Access | Times Cited: 31
Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms
Gianluigi Savarese, Javed Butler, Lars H. Lund, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 10, pp. 2231-2252
Open Access | Times Cited: 31
The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer
Qi‐Yue Chen, Xiaobo Huang, Yajun Zhao, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1904-1920
Open Access | Times Cited: 18
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis
Siyu Li, Zhe Chen, Liang Huang, et al.
Pediatric Drugs (2022) Vol. 24, Iss. 5, pp. 447-464
Closed Access | Times Cited: 18
Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis
Johanna Melin, Maria Forslund, Simon Alesi, et al.
Clinical Endocrinology (2023) Vol. 100, Iss. 2, pp. 149-163
Open Access | Times Cited: 9
An integrated approach to identify environmental modulators of genetic risk factors for complex traits
Brunilda Balliu, Iván Cárcamo-Orive, Michael J. Gloudemans, et al.
The American Journal of Human Genetics (2021) Vol. 108, Iss. 10, pp. 1866-1879
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top